Company to provide a clinical update on the EDIT-301 RUBY trial for SCD and EdiTHAL trial for TDT in December at the American Society of Hematology Annual Meeting and in a Company-sponsored webinar .
CAMBRIDGE, Mass., Sept. 25, 2023 Editas Medicine, Inc. , a clinical-stage genome editing company, today announced the appointment of Caren Deardorf as the Company’s first Chief Commercial and.
Techtextil North America And Texprocess Americas Extend Early Bird Pricing And Announce Symposium Schedules textileworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from textileworld.com Daily Mail and Mail on Sunday newspapers.
Ohio Soybean Council wins award for research, development galioninquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from galioninquirer.com Daily Mail and Mail on Sunday newspapers.